公开(公告)号：US20250166185A1

公开(公告)日：2025-05-22

申请号：US19024966

申请日：2025-01-16

Applicant: ELUCID BIOIMAGING INC.

Inventor： Andrew J. BUCKLER ,  Kjell JOHNSON ,  Xiaonan MA ,  Keith A. MOULTON ,  David S. PAIK

IPC: G06T7/00 ,  G06F18/211 ,  G06F18/214 ,  G06F18/24 ,  G06N3/08 ,  G06N20/00 ,  G06T3/00 ,  G06T5/73 ,  G06T7/11 ,  G06V10/25 ,  G06V10/764 ,  G06V20/69

Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.

公开(公告)号：US12229957B2

公开(公告)日：2025-02-18

申请号：US18307316

申请日：2023-04-26

Applicant: ELUCID BIOIMAGING INC.

Inventor： Andrew J. Buckler ,  Kjell Johnson ,  Xiaonan Ma ,  Keith A. Moulton ,  David S. Paik

IPC: G06T7/00 ,  G06F18/211 ,  G06F18/214 ,  G06F18/24 ,  G06N3/08 ,  G06N20/00 ,  G06T3/00 ,  G06T5/73 ,  G06T7/11 ,  G06V10/25 ,  G06V10/764 ,  G06V20/69

Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.

公开(公告)号：US20240394841A1

公开(公告)日：2024-11-28

申请号：US18794349

申请日：2024-08-05

Applicant: ELUCID BIOIMAGING INC.

Inventor： Andrew J. BUCKLER ,  Changguo JI ,  Murali AYYAPILLAI

IPC: G06T5/50 ,  A61B6/00 ,  A61B6/42 ,  A61B6/46 ,  A61B6/50 ,  G06T7/00 ,  G06T7/174

Abstract: Systems and methods for improving soft tissue contrast, characterizing tissue, classifying phenotype, stratifying risk, and performing multi-scale modeling aided by multiple energy or contrast excitation and evaluation are provided. The systems and methods can include single and multi-phase acquisitions and broad and local spectrum imaging to assess atherosclerotic plaque tissues in the vessel wall and perivascular space.

公开(公告)号：US20240371000A1

公开(公告)日：2024-11-07

申请号：US18756734

申请日：2024-06-27

Applicant: ELUCID BIOIMAGING INC.

Inventor： Andrew J. BUCKLER

IPC: G06T7/00 ,  A61B5/02 ,  A61B6/50 ,  A61B8/08 ,  G06T7/11

Abstract: A system including a hierarchical analytics framework that can utilize a first set of machine learned algorithms to identify and quantify a set of biological properties utilizing medical imaging data is provided. System can segment the medical imaging data based on the quantified biological properties to delineate existence of perivascular adipose tissue. The system can also segment the medical imaging data based on the quantified biological properties to determine a lumen boundary and/or determine a cap thickness based on a minimum distance between the lumen boundary and LRNC regions.

公开(公告)号：US20240212143A1

公开(公告)日：2024-06-27

申请号：US18415137

申请日：2024-01-17

Applicant: ELUCID BIOIMAGING INC.

Inventor： Andrew J. BUCKLER ,  Kjell JOHNSON ,  Xiaonan MA ,  Keith A. MOULTON ,  David S. PAIK

IPC: G06T7/00 ,  G06F18/211 ,  G06F18/214 ,  G06F18/24 ,  G06N3/08 ,  G06N20/00 ,  G06T3/00 ,  G06T5/73 ,  G06T7/11 ,  G06V10/25 ,  G06V10/764 ,  G06V20/69

CPC classification number: G06T7/0012 ,  G06F18/211 ,  G06F18/2148 ,  G06F18/24 ,  G06N3/08 ,  G06N20/00 ,  G06T3/00 ,  G06T5/73 ,  G06T7/11 ,  G06V10/25 ,  G06V10/764 ,  G06V20/69 ,  G06T2207/10048 ,  G06T2207/10081 ,  G06T2207/10088 ,  G06T2207/10101 ,  G06T2207/10104 ,  G06T2207/10108 ,  G06T2207/10132 ,  G06T2207/20081 ,  G06T2207/30096 ,  G06T2207/30104

Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.

公开(公告)号：US20240161295A1

公开(公告)日：2024-05-16

申请号：US18545542

申请日：2023-12-19

Applicant: ELUCID BIOIMAGING INC.

Inventor： Andrew J. BUCKLER ,  Kjell JOHNSON ,  Xiaonan MA ,  Keith A. MOULTON ,  David S. PAIK

IPC: G06T7/00 ,  G06F18/211 ,  G06F18/214 ,  G06F18/24 ,  G06N3/08 ,  G06N20/00 ,  G06T3/00 ,  G06T5/73 ,  G06T7/11 ,  G06V10/25 ,  G06V10/764 ,  G06V20/69

CPC classification number: G06T7/0012 ,  G06F18/211 ,  G06F18/2148 ,  G06F18/24 ,  G06N3/08 ,  G06N20/00 ,  G06T3/00 ,  G06T5/73 ,  G06T7/11 ,  G06V10/25 ,  G06V10/764 ,  G06V20/69 ,  G06T2207/10048 ,  G06T2207/10081 ,  G06T2207/10088 ,  G06T2207/10101 ,  G06T2207/10104 ,  G06T2207/10108 ,  G06T2207/10132 ,  G06T2207/20081 ,  G06T2207/30096 ,  G06T2207/30104

Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.

公开(公告)号：US20240087742A1

公开(公告)日：2024-03-14

申请号：US18243132

申请日：2023-09-07

Applicant: Elucid Bioimaging Inc.

Inventor： Andrew J. Buckler ,  Ulf Hedin ,  Ljubica Matic ,  Matthew Phillips

IPC: G16H50/20 ,  G06N20/00 ,  G16H20/10 ,  G16H50/50

CPC classification number: G16H50/20 ,  G06N20/00 ,  G16H20/10 ,  G16H50/50 ,  A61B6/504

Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.

公开(公告)号：US11887713B2

公开(公告)日：2024-01-30

申请号：US17838147

申请日：2022-06-10

Applicant: Elucid Bioimaging Inc.

Inventor： Andrew J. Buckler ,  Ulf Hedin ,  Ljubica Matic ,  Matthew Phillips

IPC: G16H20/10 ,  G16B5/00

CPC classification number: G16H20/10 ,  G16B5/00

Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-diabetic therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.

公开(公告)号：US11869186B2

公开(公告)日：2024-01-09

申请号：US17838140

申请日：2022-06-10

Applicant: Elucid Bioimaging Inc.

Inventor： Andrew J. Buckler ,  Ulf Hedin ,  Ljubica Matic ,  Matthew Phillips

IPC: G06T7/00 ,  A61B5/055 ,  G16B5/00 ,  G16C20/30 ,  G16H20/00

CPC classification number: G06T7/0012 ,  A61B5/055 ,  G16B5/00 ,  G16C20/30 ,  G16H20/00 ,  G06T2207/10088 ,  G06T2207/30101

Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a combination of any two or more therapies selected from a lipid-lowering therapy, an anti-inflammatory therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.

公开(公告)号：US20230368365A9

公开(公告)日：2023-11-16

申请号：US17314767

申请日：2021-05-07

Applicant: ELUCID BIOIMAGING INC.

Inventor： Andrew J. BUCKLER ,  Mark A. Buckler

IPC: G06T7/00 ,  G06K9/32 ,  G06K9/46 ,  G06T11/00 ,  G16H30/20 ,  G16H10/60 ,  G16H50/20 ,  G16H30/40 ,  G16H70/60 ,  A61B6/00

CPC classification number: G06T7/001 ,  G06K9/3241 ,  G06K9/4652 ,  G06T11/008 ,  G16H30/20 ,  G16H10/60 ,  G16H50/20 ,  G16H30/40 ,  G16H70/60 ,  A61B6/504 ,  A61B6/5247 ,  G06T2207/10116 ,  G06T2207/20081 ,  G06K9/00979

Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.